- Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1
- Biogen is dedicated to…
Category: 6. Business
-
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
-

Linking complex microbial interactions and dysbiosis through a disordered Lotka–Volterra model
We thus collect all the parameters estimated from the data in a vector . As we will better detail in the Methods, we develop a moment matching inference algorithm to infer the model parameters , as depicted in Figure 1. The…
Continue Reading
-

Multi-Criteria Decision Making for Decommissioning Projects
Multi-Criteria Decision Making
Over 60 participants from 30 countries and three international organizations discussed how their countries have used multi-criteria decision making (MCDM) to plan decommissioning…
Continue Reading
-

Honigman Welcomes Kirkland Litigator Michael Kraft to its Growing Chicago Litigation Team: Law Firm, Attorneys, Lawyers
CHICAGO – Honigman LLP announced today that Michael Kraft joined the firm’s Litigation Department and Privacy, Products, and Class Actions Practice Group in its Chicago office. He comes to Honigman after nearly five years with Kirkland & Ellis….
Continue Reading
-

Luxury with roots and a vision for the future
From historic Jerusalem to the shoreline of Tel Aviv–Jaffa. Two prime-location projects demonstrate why reputation, certainty, and meticulous planning are the key words in the luxury real estate market.While the Israeli real estate market has…
Continue Reading
-

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research
News Summary:
- NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address…
Continue Reading
-

Arkin raises $100m for early-stage biotech fund
The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund.
Continue Reading
-

ABB chosen to supply technology for BC Ferries’ New Major Vessels
- ABB’s integrated power, propulsion and control solution has been chosen for BC Ferries’ four new hybrid-electric major vessels
- The New Major Vessels have been designed to minimize emissions and underwater radiated noise (URN), with…
Continue Reading
-

A geometric shape regularity effect in the human brain
Long before the invention of writing, the very first detectable graphic productions of prehistoric humans were highly regular non-pictorial geometric signs such as parallel lines, zig-zags, triangular, or checkered patterns (Henshilwood et…
Continue Reading
-

How digital business models are evolving in the age of agentic AI
Researchers have identified four new business models for the era of agentic artificial intelligence:
- Existing+. Augment an existing business…
Continue Reading